Strictureplasty versus bowel resection for the surgical management of fibrostenotic Crohn's disease: a systematic review and meta-analysis.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Apr 2020
Historique:
accepted: 08 01 2020
pubmed: 13 2 2020
medline: 18 12 2020
entrez: 13 2 2020
Statut: ppublish

Résumé

Strictureplasty (SPX) conserves bowel length and minimizes the risk of developing short bowel syndrome in patients undergoing surgery for Crohn's disease (CD). However, SPX may be associated with a higher risk of recurrence compared with bowel resection (BR). We sought to compare morbidity and recurrence following SPX and BR in patients with fibrostenotic CD. A systematic review was performed according to PRISMA and MOOSE guidelines. Observational studies that compared outcomes of CD patients undergoing either SPX or BR were identified. Log hazard ratios (InHR) for recurrence-free survival (RFS) and their standard errors were calculated from Kaplan-Meier plots or Cox regression models and pooled using the inverse variance method. Dichotomous variables were pooled as odds ratios (OR) using the Mantel-Haenszel method. Continuous variables were pooled as weighted mean differences. Twelve studies of 1026 CD patients (SPX n = 444, 43.27%; BR with or without SPX n = 582, 56.72%) were eligible for inclusion. There was an increased likelihood of disease recurrence with SPX than with BR (OR 1.61; 95% CI, 1.03, 2.52; p = 0.04; I SPX should only be performed in those patients with Crohn's strictures that are at high risk for short bowel syndrome and intestinal failure; otherwise, BR is the favored surgical technique for the management of fibrostenotic CD.

Sections du résumé

BACKGROUND BACKGROUND
Strictureplasty (SPX) conserves bowel length and minimizes the risk of developing short bowel syndrome in patients undergoing surgery for Crohn's disease (CD). However, SPX may be associated with a higher risk of recurrence compared with bowel resection (BR).
AIM OBJECTIVE
We sought to compare morbidity and recurrence following SPX and BR in patients with fibrostenotic CD.
METHODS METHODS
A systematic review was performed according to PRISMA and MOOSE guidelines. Observational studies that compared outcomes of CD patients undergoing either SPX or BR were identified. Log hazard ratios (InHR) for recurrence-free survival (RFS) and their standard errors were calculated from Kaplan-Meier plots or Cox regression models and pooled using the inverse variance method. Dichotomous variables were pooled as odds ratios (OR) using the Mantel-Haenszel method. Continuous variables were pooled as weighted mean differences.
RESULTS RESULTS
Twelve studies of 1026 CD patients (SPX n = 444, 43.27%; BR with or without SPX n = 582, 56.72%) were eligible for inclusion. There was an increased likelihood of disease recurrence with SPX than with BR (OR 1.61; 95% CI, 1.03, 2.52; p = 0.04; I
CONCLUSION CONCLUSIONS
SPX should only be performed in those patients with Crohn's strictures that are at high risk for short bowel syndrome and intestinal failure; otherwise, BR is the favored surgical technique for the management of fibrostenotic CD.

Identifiants

pubmed: 32048011
doi: 10.1007/s00384-020-03507-z
pii: 10.1007/s00384-020-03507-z
doi:

Types de publication

Comparative Study Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

705-717

Références

Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8(4):244–250
doi: 10.1097/00054725-200207000-00002
Gomollon F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. Journal of Crohn’s & Colitis. 11(1):3–25
doi: 10.1093/ecco-jcc/jjw168
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D’Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude C, Rutgeerts P, SONIC Study Group (2010) Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 362(15):1383–1395
doi: 10.1056/NEJMoa0904492
Rieder F, Fiocchi C, Rogler G (2017) Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases. Gastroenterology 152(2):340–350.e346
doi: 10.1053/j.gastro.2016.09.047
Bouguen G, Peyrin-Biroulet L (2011) Surgery for adult Crohn’s disease: what is the actual risk? Gut 60(9):1178–1181. https://doi.org/10.1136/gut.2010.234617
Yamamoto T (2005) Factors affecting recurrence after surgery for Crohn’s disease. World Journal of Gastroenterology Review 11(26):3971–3979
doi: 10.3748/wjg.v11.i26.3971
Thirlby RC, Land JC, Fenster LF, Lonborg R (1998) Effect of surgery on health-related quality of life in patients with inflammatory bowel disease: a prospective study. Arch Surg 133(8):826–832
doi: 10.1001/archsurg.133.8.826
Mege D, Garrett K, Milsom J, Sonoda T, Michelassi F (2019) Changing trends in surgery for abdominal Crohn’s disease. Color Dis 21(2):200–207
doi: 10.1111/codi.14450
Kinash RG, Fischer D, Lukie B, Carr T (1993) Inflammatory bowel disease impact and patient characteristics. Gastroenterology Nursing 15(4):147–154 
doi: 10.1097/00001610-199302000-00003
Fazi M, Giudici F, Luceri C, Pronesti M, Tonelli F (2016) Long-term results and recurrence-related risk factors for Crohn disease in patients undergoing side-to-side isoperistaltic strictureplasty. JAMA Surgery 151(5):452–460
doi: 10.1001/jamasurg.2015.4552
Uchino M, Ikeuchi H, Bando T, Matsuoka H, Takahashi Y, Takesue Y, Matsumoto T, Tomita N (2012) Risk factors for short bowel syndrome in patients with Crohn’s disease. Surg Today 42(5):447–452
doi: 10.1007/s00595-011-0098-0
Lee E, Papaioannou N (1982) Minimal surgery for chronic obstruction in patients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl 64(4):229–233
pubmed: 7092090 pmcid: 2494172
Yamamoto T, Fazio VW, Tekkis PP (2007) Safety and efficacy of strictureplasty for Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum 50(11):1968–1986
doi: 10.1007/s10350-007-0279-5
Ambe R, Campbell L, Cagir B (2012) A comprehensive review of strictureplasty techniques in Crohn’s disease: types, indications, comparisons, and safety. J Gastrointest Surg 16(1):209–217
doi: 10.1007/s11605-011-1651-2
Jobanputra S, Weiss EG (2007) Strictureplasty. Clinics in Colon and Rectal Surgery 20(4):294–302
doi: 10.1055/s-2007-991028 pubmed: 2780218 pmcid: 2780218
de Buck van Overstraeten A, Wolthuis AM, D’Hoore A (2016) Modified side-to-side isoperistaltic strictureplasty over the ileocaecal valve for the surgical treatment of terminal ileal Crohn’s disease: the ultimate bowel sparing technique? Colorectal Disease 18(8):O311–O313
doi: 10.1111/codi.13420
Van Stappen J, De Buck Van Overstraeten A, Ferrante M et al (2017) Long-term outcome and endoscopic healing rates following long modified side-to-side strictureplasties. Journal of Crohn's and Colitis Conference Abstract 11:S273
doi: 10.1093/ecco-jcc/jjx002.509
Campbell L, Ambe R, Weaver J, Marcus SM, Cagir B (2012) Comparison of conventional and nonconventional strictureplasties in Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum 55(6):714–726
doi: 10.1097/DCR.0b013e31824f875a
Thompson JS (2000) Comparison of massive vs. repeated resection leading to short bowel syndrome. J Gastrointest Surg 4(1):101–104
doi: 10.1016/S1091-255X(00)80039-6
Reese GE, Purkayastha S, Tilney HS, von Roon A, Yamamoto T, Tekkis PP (2007) Strictureplasty vs resection in small bowel Crohn’s disease: an evaluation of short-term outcomes and recurrence. Colorectal Disease 9(8):686–694
doi: 10.1111/j.1463-1318.2006.01114.x
Borley NR, Mortensen NJ, Jewell DP (1997) Preventing postoperative recurrence of Crohn’s disease. Br J Surg 84(11):1493–1502
doi: 10.1002/bjs.1800841104
Greenstein AJ, Sachar DB, Pasternack BS, Janowitz HD (1975) Reoperation and recurrence in Crohn’s colitis and ileocolitis crude and cumulative rates. N Engl J Med 293(14):685–690
doi: 10.1056/NEJM197510022931403
Ozuner G, Fazio VW, Lavery IC, Milsom JW, Strong SA (1996) Reoperative rates for Crohn’s disease following strictureplasty. Long-term analysis. Dis Colon Rectum 39(11):1199–1203
doi: 10.1007/BF02055108
Yamamoto T, Bain IM, Allan RN, Keighley MR (1999) An audit of strictureplasty for small-bowel Crohn’s disease. Dis Colon Rectum 42(6):797–803
doi: 10.1007/BF02236939
Tonelli F, Ficari F (2000) Strictureplasty in Crohn’s disease: surgical option. Diseases of the Colon and Rectum 43(7):920–926
doi: 10.1007/BF02237351
Cristaldi M, Sampietro GM, Danelli PG, Bollani S, Bianchi Porro G, Taschieri AM (2000) Long-term results and multivariate analysis of prognostic factors in 138 consecutive patients operated on for Crohn’s disease using "bowel-sparing" techniques. Am J Surg 179(4):266–270
doi: 10.1016/S0002-9610(00)00334-2
Broering DC, Eisenberger CF, Koch A, Bloechle C, Knoefel WT, Izbicki JR (2001) Quality of life after surgical therapy of small bowel stenosis in Crohn’s disease. Dig Surg 18(2):124–130
doi: 10.1159/000050112
Sampietro GM, Cristaldi M, Maconi G et al (2004) A prospective, longitudinal study of nonconventional strictureplasty in Crohn’s disease. Journal of American College of Surgeons 199:8–20
doi: 10.1016/j.jamcollsurg.2004.01.039
Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP, Mortensen NJ (2006) Long-term follow-up of strictureplasty for Crohn’s disease. Br J Surg 93(4):475–482
doi: 10.1002/bjs.5179
Fichera A, Lovadina S, Rubin M, Cimino F, Hurst RD, Michelassi F (2006) Patterns and operative treatment of recurrent Crohn’s disease: a prospective longitudinal study. Surgery. 140(4):649–654
doi: 10.1016/j.surg.2006.07.011
Roy P, Kumar D (2006) Intervention-free interval following strictureplasty for Crohn’s disease. World J Surg:301020–301026
Tonelli F, Fazi M, Di Martino C (2010) Ileocecal strictureplasty for Crohn’s disease: long-term results and comparison with ileocecal resection. World J Surg 34(12):2860–2866
doi: 10.1007/s00268-010-0708-9
Romeo E, Jasonni V, Caldaro T et al (2012) Strictureplasty and intestinal resection: different options in complicated pediatric-onset Crohn disease. Journal of Pediatric Surgery Conference Paper 47(5):944–948
doi: 10.1016/j.jpedsurg.2012.01.054
Bamford R, Hay A, Kumar D (2014) Resection leads to less recurrence than strictureplasty in a paediatric population with obstructive Crohn’s disease. Surgery Research and Practice 2014:709045
doi: 10.1155/2014/709045 pubmed: 4208455 pmcid: 4208455
Michelassi F, Mege D, Rubin M, Hurst RD (2019) Long-term results of the side-to-side isoperistaltic strictureplasty in Crohn disease: 25-year follow-up and outcomes. Ann Surg
Lindhagen T, Ekelund G, Leandoer L, Hildell J, Lindstrom C, Wenckert A (1983) Recurrence rate after surgical treatment of Crohn’s disease. Scand J Gastroenterol 18(8):1037–1044
doi: 10.3109/00365528309181837
Williams JG, Wong WD, Rothenberger DA, Goldberg SM (1991) Recurrence of Crohn’s disease after resection. Br J Surg 78(1):10–19
doi: 10.1002/bjs.1800780106
de Buck van Overstraeten A, Vermeire S, Vanbeckevoort D et al (2016) Modified side-to-side isoperistaltic strictureplasty over the ileocaecal valve: an alternative to ileocaecal resection in extensive terminal ileal Crohn’s disease. Journal of Crohn’s & Colitis. 10(4):437–442
doi: 10.1093/ecco-jcc/jjv230
Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharmacol Ther 23(8):1097–1104
doi: 10.1111/j.1365-2036.2006.02854.x
Coffey JC, O’Leary DP, Kiernan MG, Faul P (2016) The mesentery in Crohn’s disease: friend or foe? Curr Opin Gastroenterol 32(4):267–273
doi: 10.1097/MOG.0000000000000280
Borley NR, Mortensen NJ, Jewell DP, Warren BF (2000) The relationship between inflammatory and serosal connective tissue changes in ileal Crohn’s disease: evidence for a possible causative link. J Pathol 190(2):196–202
doi: 10.1002/(SICI)1096-9896(200002)190:2<196::AID-PATH513>3.0.CO;2-5
Guedj K, Abitbol Y, Cazals-Hatem D et al (2019) Adipocytes orchestrate the formation of tertiary lymphoid organs in the creeping fat of Crohn’s disease affected mesentery. J Autoimmun
Coffey CJ, Kiernan MG, Sahebally SM et al (2018) Inclusion of the mesentery in ileocolic resection for Crohn’s disease is associated with reduced surgical recurrence. Journal of Crohn’s & Colitis. 12(10):1139–1150
doi: 10.1093/ecco-jcc/jjx187
de Groof EJ, van der Meer JHM, Tanis PJ, de Bruyn JR, van Ruler O, D’Haens GRAM, van den Brink G, Bemelman WA, Wildenberg ME, Buskens CJ (2019) Persistent mesorectal inflammatory activity is associated with complications after proctectomy in Crohn’s disease. Journal of Crohn’s & Colitis 13(3):285–293
doi: 10.1093/ecco-jcc/jjy131
Ryan JM, Rogers AC, O’Toole A, Burke JP (2019) Meta-analysis of histological margin positivity in the prediction of recurrence after Crohn’s resection. Dis Colon Rectum 62(7):882–892
doi: 10.1097/DCR.0000000000001407
Jeejeebhoy KN (2002) Short bowel syndrome: a nutritional and medical approach. CMAJ. 166(10):1297–1302
pubmed: 12041848 pmcid: 111082
Wright EK, Kamm MA, De Cruz P et al (2015) Effect of intestinal resection on quality of life in Crohn’s disease. Journal of Crohn's & Colitis 9(6):452–462
doi: 10.1093/ecco-jcc/jjv058
Wright EK, Kamm MA (2015) Impact of drug therapy and surgery on quality of life in Crohn’s disease: a systematic review. Inflamm Bowel Dis 21(5):1187–1194
doi: 10.1097/MIB.0000000000000271
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven A, Brink MA, Consten ECJ, van Wagensveld B, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA, LIR!C study group (2017) Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. The Lancet Gastroenterology & Hepatology 2(11):785–792
doi: 10.1016/S2468-1253(17)30248-0
Ha FJ, Thong L, Khalil H (2017) Quality of life after intestinal resection in patients with Crohn disease: a systematic review. Dig Surg 34(5):355–363
doi: 10.1159/000453590
Michelassi F (2016) Long-term results of side-to-side isoperistaltic strictureplasty for Crohn disease. JAMA Surg 151(5):461. https://doi.org/10.1001/jamasurg.2015.4661
doi: 10.1001/jamasurg.2015.4661 pubmed: 26720756
Mitchell JE, Breuer RI, Zuckerman L, Berlin J, Schilli R, Dunn JK (1980) The colon influences ileal resection diarrhea. Dig Dis Sci 25(1):33–41
doi: 10.1007/BF01312730
Johnston WF, Stafford C, Francone TD, Read TE, Marcello PW, Roberts PL et al (2017) What is the risk of anastomotic leak after repeat instinal resection in patients with Crohn’s disease? Dis Colon Rectum 60(12):1299–1306
doi: 10.1097/DCR.0000000000000946
D’Haens G, Baert F, van Assche G et al (2008) Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet (London, England) 371(9613):660–667
doi: 10.1016/S0140-6736(08)60304-9
Baert F, Moortgat L, Van Assche G et al (2010) Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterology 138(2):463–468 quiz e410–461
doi: 10.1053/j.gastro.2009.09.056
Amezaga AJ, Van Assche G (2016) Practical approaches to "top-down" therapies for Crohn’s disease. Current Gastroenterology Reports 18(7):35
doi: 10.1007/s11894-016-0507-z
Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, Harmsen WS, Zinsmeister AR (1999) Clinical course and costs of care for Crohn’s disease: Markov model analysis of a population-based cohort. Gastroenterology. 117(1):49–57
doi: 10.1016/S0016-5085(99)70549-4
Latella G, Cocco A, Angelucci E et al (2009) Clinical course of Crohn’s disease first diagnosed at surgery for acute abdomen. Dig Liver Dis Article 41(4):269–276
doi: 10.1016/j.dld.2008.09.010
An V, Cohen L, Lawrence M, Thomas M, Andrews J, Moore J (2016) Early surgery in Crohn’s disease a benefit in selected cases. World Journal of Gastrointestinal Surgery 8(7):492–500
doi: 10.4240/wjgs.v8.i7.492 pubmed: 4942749 pmcid: 4942749
Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R (2007) Early versus late surgery for ileo-caecal Crohn’s disease. Aliment Pharmacol Ther Review 26(10):1303–1312
doi: 10.1111/j.1365-2036.2007.03515.x
Lee JM, Lee KM, Kim JS et al (2018) Postoperative course of Crohn disease according to timing of bowel resection: results from the CONNECT Study. Medicine (Baltimore) 97(16):e0459
doi: 10.1097/MD.0000000000010459
Golovics PA, Lakatos L, Nagy A et al (2013) Is early limited surgery associated with a more benign disease course in Crohn’s disease? World Journal of Gastroenterology 19(43):7701–7710
doi: 10.3748/wjg.v19.i43.7701 pubmed: 3837269 pmcid: 3837269
Eshuis EJ, Stokkers PC, Bemelman WA (2010a) Decision-making in ileocecal Crohn’s disease management: surgery versus pharmacotherapy. Expert Review of Gastroenterology & Hepatology 4(2):181–189
doi: 10.1586/egh.10.3
Eshuis EJ, Slors JF, Stokkers PC, Sprangers MA, Ubbink DT, Cuesta MA, Pierik EG, Bemelman WA (2010b) Long-term outcomes following laparoscopically assisted versus open ileocolic resection for Crohn’s disease. Br J Surg 97(4):563–568
doi: 10.1002/bjs.6918
Latella G, Caprilli R, Travis S (2011) In favour of early surgery in Crohn’s disease: a hypothesis to be tested. Journal of Crohn’s & Colitis. 5(1):1–4
doi: 10.1016/j.crohns.2010.11.003
Regueiro M, Velayos F, Greer JB et al (2017) American Gastroenterological Association Institute technical review on the management of Crohn’s disease after surgical resection. Gastroenterology 152(1):277–295.e273
doi: 10.1053/j.gastro.2016.10.039
Shapiro S (1994a) Meta-analysis/Shmeta-analysis. Am J Epidemiol 140(9):771–778
doi: 10.1093/oxfordjournals.aje.a117324
Shapiro S (1994b) Is there is or is there ain’t no baby? Dr. Shapiro replies to Drs. Petitti and Greenland. Am J Epidemiol 140(9):788–791
doi: 10.1093/oxfordjournals.aje.a117327
Blettner M, Sauerbrei W, Schlehofer B, Scheuchenpflug T, Friedenreich C (1999) Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol 28(1):1–9
doi: 10.1093/ije/28.1.1
Egger M, Schneider M, Smith GD (1998) Meta-analysis spurious precision? Meta-analysis of observational studies. Bmj. 316(7125):140–144
doi: 10.1136/bmj.316.7125.140 pubmed: 2665367 pmcid: 2665367
Petitti DB (1994) Of babies and bathwater. Am J Epidemiol 140(9):779–782
doi: 10.1093/oxfordjournals.aje.a117325
Greenland S (1994) Can meta-analysis be salvaged? Am J Epidemiol 140(9):783–787
doi: 10.1093/oxfordjournals.aje.a117326

Auteurs

Waqas T Butt (WT)

Department of Surgery, Tallaght University Hospital, Tallaght, Dublin, D24 NR0A, Ireland. wtbutt@hotmail.com.

Éanna J Ryan (ÉJ)

Department of Surgery, Tallaght University Hospital, Tallaght, Dublin, D24 NR0A, Ireland.
School of Medicine, University College Dublin, Dublin, Ireland.

Michael R Boland (MR)

Department of Surgery, Tallaght University Hospital, Tallaght, Dublin, D24 NR0A, Ireland.

Eilis M McCarthy (EM)

Department of Gastroenterology, Tallaght University Hospital, Dublin, Ireland.

Joseph Omorogbe (J)

Department of Gastroenterology, Tallaght University Hospital, Dublin, Ireland.

Karl Hazel (K)

Department of Gastroenterology, Tallaght University Hospital, Dublin, Ireland.

Gary A Bass (GA)

Department of Surgery, Tallaght University Hospital, Tallaght, Dublin, D24 NR0A, Ireland.

Paul C Neary (PC)

Department of Surgery, Tallaght University Hospital, Tallaght, Dublin, D24 NR0A, Ireland.
School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.

Dara O Kavanagh (DO)

Department of Surgery, Tallaght University Hospital, Tallaght, Dublin, D24 NR0A, Ireland.
School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.

Deirdre McNamara (D)

Department of Gastroenterology, Tallaght University Hospital, Dublin, Ireland.
School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.

James M O'Riordan (JM)

Department of Gastroenterology, Tallaght University Hospital, Dublin, Ireland.
School of Medicine, Trinity College Dublin, The University of Dublin, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH